Loss of heterozygosity analysis was carried out on 41 ovarian adenocarcinomas with the D17S1293 and D17S933 microsatellite markers, which are located 0.02 Mb proximal and 0.61 Mb distal to CCL2 at 32.73 Mb (www.ncbi.nlm.nih.gov/). Here, CCL2 is linked to ovarian adenocarcinoma.